Axinn Assisted Actavis in Resolving Ten-Year-Old Dispute with Pfizer
March 1, 2012
"Axinn assisted Actavis in resolving a ten-year-old dispute with Pfizer over its Neurontin (gabapentin) epilepsy drug during the jury trial of the case. Pfizer sued Purepac/Actavis, Teva and IVAX in 2000, claiming that their generic gabapentin products infringed a Pfizer patent on specific gabapentin formulations, and resulting in Pfizer losing $2 billion in the first year of generic competition. Actavis succeeded at trial in barring several of Pfizer's expert witness opinions on the patent infringement issue. The companies had completed two weeks of what was expected to be a six-week jury trial before the settlement was announced.
Axinn's Fran Morrison, who led the Actavis trial team, stated, "We are thrilled to be able to assist Actavis in resolving this case on favorable terms, and in avoiding a significant claim for damages. The outcome of the case reflects the hard work of the Actavis management and legal teams, and the Axinn trial team. We expect that Actavis will continue to prosper as it moves beyond this long-running dispute."
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ACI 12th Annual Summit for Women Leaders in Life Sciences Law
Speaking Engagement
Intellectual Property
National LGBTQ+ Bar Association Lavender Law Conference and Career Fair 2025
Sponsorship
National Bar Association 100th Annual Convention and Exhibits
Sponsorship
Antitrust
Keeping Pace: Updates in Cartel Enforcement
Webinar
Antitrust
Hanging in the Balance: Supreme Court Declines to Decide the Uninjured Class Member Question in Labcorp v. Davis
Axinn Viewpoints
Antitrust
New Incentives, New Rewards: What You Need to Know About the Antitrust Division’s First-Ever Whistleblower Rewards Program
Axinn Viewpoints
Antitrust
Informa Antitrust Midwest
Speaking Engagement
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
How I Made Partner: 'Show Up and Build Rapport With Colleagues and Clients,' Says Michael O'Mara of Axinn Veltrop & Harkrider
Media Mentions
Antitrust
Axinn Counsel Rebecca Clegg Named 2025 MCCA Rising Star
Awards & Recognitions
Intellectual Property